ID: ALA3422334

Max Phase: Preclinical

Molecular Formula: C9H6N4S

Molecular Weight: 202.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Sc1nnc2c(n1)[nH]c1ccccc12

Standard InChI:  InChI=1S/C9H6N4S/c14-9-11-8-7(12-13-9)5-3-1-2-4-6(5)10-8/h1-4H,(H2,10,11,13,14)

Standard InChI Key:  RPEJKVRRTJDBSN-UHFFFAOYSA-N

Associated Targets(non-human)

Aldose reductase-related protein 1 30 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Aldose reductase 4007 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.24Molecular Weight (Monoisotopic): 202.0313AlogP: 1.79#Rotatable Bonds: 0
Polar Surface Area: 54.46Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.60CX Basic pKa: 1.68CX LogP: 1.71CX LogD: 1.71
Aromatic Rings: 3Heavy Atoms: 14QED Weighted: 0.55Np Likeness Score: -1.24

References

1. Stefek M, Soltesova Prnova M, Majekova M, Rechlin C, Heine A, Klebe G..  (2015)  Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.,  58  (6): [PMID:25695864] [10.1021/jm5015814]

Source